Annals of Oncology

in this issue
pp. 613-613(1)

The treatment of lymphoma complicating autoimmune disease: two birds with one stone?
pp. 615-618(4)
Author: Mikuls, TR

Potential risks and benefits of radiation therapy as adjuvant treatment in patients with low-risk carcinoma of the mammary gland: taking cutaneous postradiation angiosarcoma as an opportunity for a critical appraisal of postoperative radiotherapy
pp. 619-621(3)
Author: Bernier, J

Feasibility and safety of autotransplants with noncryopreserved marrow or peripheral blood stem cells: a systematic review
pp. 623-632(10)
Authors: Wannesson, L; Panzarella, T; Mikhael, J; Keating, A

The illness trajectory of elderly cancer patients across cultures: SIOG position paper
pp. 633-638(6)
Authors: Surbone, A; Kagawa-Singer, M; Terret, C; Baider, L

A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment
pp. 639-646(8)
Authors: Moseley, AL; Carati, CJ; Piller, NB

Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases
pp. 647-651(5)
Authors: Wöhrer, S; Troch, M; Zwerina, J; Schett, G; Skrabs, C; Gaiger, A; Jaeger, U; Zielinski, CC; Raderer, M

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience
pp. 652-657(6)
Authors: Rodríguez, J; Conde, E; Gutiérrez, A; Arranz, R; León, Á; Marín, J; Bendandi, M; Albo, C; On behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea,

Cost-effective therapy remission assessment in lymphoma patients using 2-[fluorine-18]fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography: is an end of treatment exam necessary in all patients?
pp. 658-664(7)
Authors: Strobel, K; Schaefer, NG; Renner, C; Veit-Haibach, P; Husarik, D; Koma, AY; Hany, TF

Primary central nervous system lymphoma treated with high-dose methotrexate, high-dose busulfan/thiotepa, autologous stem-cell transplantation and response-adapted whole-brain radiotherapy: results of the multicenter Ostdeutsche Studiengruppe Hämato-Onkologie OSHO-53 phase II study
pp. 665-671(7)
Authors: Montemurro, M; Kiefer, T; Schüler, F; Al-Ali, HK; Wolf, H-H; Herbst, R; Haas, A; Helke, K; Theilig, A; Lotze, C; Hirt, C; Niederwieser, D; Schwenke, M; For the Ostdeutsche Studiengruppe Hämatologie und Onkologie,

Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma
pp. 672-678(7)
Authors: Tsai, HK; Li, S; Ng, AK; Silver, B; Stevenson, MA; Mauch, PM

Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma
pp. 679-688(10)
Authors: Evens, AM; Altman, JK; Mittal, BB; Hou, N; Rademaker, A; Patton, D; Kaminer, L; Williams, S; Duffey, S; Variakojis, D; Singhal, S; Tallman, MS; Mehta, J; Winter, JN; Gordon, LI

Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients—a double-blind, randomized study
pp. 689-693(5)
Authors: Loibl, S; Schwedler, K; von Minckwitz, G; Strohmeier, R; Mehta, KM; Kaufmann, M

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy
pp. 694-700(7)
Authors: Wilking, N; Lidbrink, E; Wiklund, T; Erikstein, B; Lindman, H; Malmström, P; Kellokumpu-Lehtinen, P; Bengtsson, N-O; Söderlund, G; Anker, G; Wist, E; Ottosson, S; Salminen, E; Ljungman, P; Holte, H; Nilsson, J; Blomqvist, C; Bergh, J

CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
pp. 701-708(8)
Authors: Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, KN; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, RD; Coates, AS; For the International Breast Cancer Study Group,

Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets
pp. 709-715(7)
Authors: Psyrri, A; Kountourakis, P; Papadimitriou, C; Markakis, S; Camp, RL; Economopoulos, T; Dimopoulos, MA

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil^®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer
pp. 716-721(6)
Authors: Andreopoulou, E; Gaiotti, D; Kim, E; Downey, A; Mirchandani, D; Hamilton, A; Jacobs, Allan; Curtin, John; Muggia, F

Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors
pp. 722-729(8)
Authors: Bellati, F; Pernice, M; Manci, N; Palaia, I; Tomao, F; Marchetti, C; Zullo, MA; Muzii, L; Angioli, R; Panici, P. Benedeth

Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II study
pp. 730-737(8)
Authors: Chau, I; Cunningham, D; Hickish, T; Massey, A; Higgins, L; Osborne, R; Botwood, N; Swaisland, A

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer
pp. 738-744(7)
Authors: Machiels, J-P; Sempoux, C; Scalliet, P; Coche, J-C; Humblet, Y; Van Cutsem, E; Kerger, J; Canon, J-L; Peeters, M; Aydin, S; Laurent, S; Kartheuser, A; Coster, B; Roels, S; Daisne, J-F; Honhon, B; Duck, L; Kirkove, C; Bonny, M-A; Haustermans, K

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial
pp. 745-751(7)
Authors: Boeck, S; Weigang-Köhler, K; Fuchs, M; Kettner, E; Quietzsch, D; Trojan, J; Stötzer, O; Zeuzem, S; Lordick, F; Köhne, C-H; Kröning, H; Steinmetz, T; Depenbrock, H; Heinemann, V

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib
pp. 752-760(9)
Authors: Hirsch, FR; Varella-Garcia, M; Cappuzzo, F; McCoy, J; Bemis, L; Xavier, AC; Dziadziuszko, R; Gumerlock, P; Chansky, K; West, H; Gazdar, AF; Crino, L; Gandara, DR; Franklin, WA; Bunn, PA

Assessment of erlotinib pharmacodynamics in tumors and skin of patients with head and neck cancer
pp. 761-767(7)
Authors: Calvo, E; Malik, SN; Siu, LL; Baillargeon, GM; Irish, J; Chin, SF; Santabarbara, P; Kreisberg, JI; Rowinsky, EK

A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity
pp. 768-774(7)
Authors: Mok, TSK; Yeo, W; Johnson, PJ; Hui, P; Ho, WM; Lam, KC; Xu, M; Chak, K; Chan, A; Wong, H; Mo, F; Zee, B

Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making
pp. 775-781(7)
Authors: Efficace, F; Osoba, D; Gotay, C; Sprangers, M; Coens, C; Bottomley, A

A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer
pp. 782-788(7)
Authors: Thomas, AL; Trarbach, T; Bartel, C; Laurent, D; Henry, A; Poethig, M; Wang, J; Masson, E; Steward, W; Vanhoefer, U; Wiedenmann, B

Detailed site distribution of melanoma and sunlight exposure: aetiological patterns from a Swiss series
pp. 789-794(6)
Authors: Bulliard, J-L; De Weck, D; Fisch, T; Bordoni, A; Levi, F

The organisation and results of first screening round of the Hungarian nationwide organised breast cancer screening programme
pp. 795-799(5)
Authors: Boncz, I; Sebestyén, A; Döbrőssy, L; Péntek, Z; Budai, A; Kovács, A; Dózsa, C; Ember, I

Small-cell carcinoma of the penile urethra: a case report and a short review of the literature
pp. 801-804(4)
Authors: Altintas, S; Blockx, N; Huizing, MT; Van den Brande, J; Hoekx, L; Bogers, JP; Van Marck, E; Vermorken, JB

Breast angiosarcoma following lumpectomy and radiotherapy for breast cancer: a case with short latent period and false negative result on biopsies
pp. 801-801(1)
Authors: Moe, M; Bertelli, G

Chronic myeloid leukemia presenting as paraneoplastic ocular myasthenia gravis
pp. 804-805(2)
Authors: Kumar, P; Jain, P; Menon, H; Purvish, P

Renal tubular acidosis due to oxaliplatin
pp. 805-806(2)
Authors: Linch, M; Cunningham, D; Mingo, O; Stiles, A; Farquhar-Smith, WP

Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell
pp. 806-808(3)
Authors: Scolyer, RA; Murali, R; Gershenwald, JE; Cochran, AJ; Thompson, JF

Antiemetic neurokinin-1 antagonist aprepitant and ifosfamide-induced encephalopathy
pp. 808-809(2)
Authors: Durand, J-P; Gourmel, B; Mir, O; Goldwasser, F